OLMA Insider Trading Activity and SEC Form 4 Filings
OLMA insider trading summary
Over the past 12 months, insiders at Olema Pharmaceuticals, Inc. (OLMA) reported 22 sales worth $21.7M by 5 insiders and no open-market purchases on SEC Form 4. Net insider selling was $21.7M.
Latest OLMA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Cyrus Harmon | Insider | Sell | $146K (12,500 @ $11.71) |
| Jul 23, 2026 | Cyrus Harmon | Insider | Sell | $145K (12,500 @ $11.58) |
| Mar 4, 2026 | Shawnte Mitchell | Chief Legal Officer | Sell | $601K (24,767 @ $24.25) |
| Mar 4, 2026 | Shawnte Mitchell | Chief Legal Officer | Sell | $6K (233 @ $24.69) |
| Mar 3, 2026 | Shawnte Mitchell | Chief Legal Officer | Sell | $345K (15,000 @ $23.01) |
| Jan 20, 2026 | Cyrus Harmon | Insider | Sell | $269K (10,000 @ $26.88) |
| Jan 14, 2026 | Cyrus Harmon | Insider | Sell | $102K (3,489 @ $29.12) |
| Jan 14, 2026 | David C. Myles | Ch. Discov. & Non-Clin Dev Off | Sell | $429K (14,997 @ $28.60) |
| Jan 14, 2026 | David C. Myles | Ch. Discov. & Non-Clin Dev Off | Sell | $1.0M (35,003 @ $28.99) |
| Jan 13, 2026 | David C. Myles | Ch. Discov. & Non-Clin Dev Off | Sell | $1.4M (49,800 @ $27.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.